Trastuzumab-associated peripheral vascular toxicity.
Pansegrau
Gary K
GK
British Columbia Cancer Agency, Fraser Valley Centre, Surrey, British Columbia, Canada.
Grant
Dennis R
DR
Norris
Brian
B
Gelmon
Karen A
KA
D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001132:Arm / Q000098:blood supply; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000601:surgery; D003520:Cyclophosphamide / Q000008:administration & dosage; D015251:Epirubicin / Q000008:administration & dosage; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008875:Middle Aged; D000068878:Trastuzumab; D014652:Vascular Diseases / Q000139:chemically induced*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D015251:Epirubicin; D003520:Cyclophosphamide; D000068878:Trastuzumab; D005472:Fluorouracil